| Stage | ACLS | % of rev | LRCX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $215M | 100.00% | $8.2B | 100.00% | LRCX ×38.20 |
| Gross profit | $91M | 42.38% | $4.3B | 52.30% | LRCX +9.9pp |
| Operating income | $20M | 9.43% | $3.3B | 39.95% | LRCX +30.5pp |
| Pre-tax income | $25M | 11.78% | $3.3B | 40.30% | LRCX +28.5pp |
| Net income | $23M | 10.82% | $2.8B | 33.50% | LRCX +22.7pp |
| Stage | ACLS | LRCX | Gap · A − B |
|---|---|---|---|
| Revenue | $215M100.00% | $8.2B100.00% | LRCX ×38.20 |
| Gross profit | 42.38%$91M | 52.30%$4.3B | LRCX +9.9pp |
| Operating income | 9.43%$20M | 39.95%$3.3B | LRCX +30.5pp |
| Pre-tax income | 11.78%$25M | 40.30%$3.3B | LRCX +28.5pp |
| Net income |
| 10.82%$23M |
| 33.50%$2.8B |
| LRCX +22.7pp |